reflex md semaglutide reviews consumer reports ReflexMD Weight Loss Injection Review About one in nine Americans

But there are early signs that GLP-1s can make a difference at the population level

Its contribution to NAION risk may actually exceed that of semaglutide in many patients

Here's what the clinical evidence shows: Semaglutide (Wegovy): In the STEP 4 trial, people taking the highest dose of semaglutide lost an average of 17.4% of their body weight over 68 weeks

The GLP-1 effects are similar to semaglutide

AEs leading to trial product discontinuation occurred in 2/62 (3%) participants in the CagriSema 2.4 mg/2.4 mg group, 2/63 (3%) participants in the CagriSema 1 mg/1 mg group, and 2/64 (3%) participants in the placebo group

The needle itself is quite thin and shortabout the width of two human hairs